Publications by authors named "Passilly-Degrace P"

Article Synopsis
  • The study investigated the effects of INV-202, a new cannabinoid type-1 receptor inverse agonist, on kidney function in a mouse model of type-1 diabetes induced by streptozotocin.
  • Mice were treated with various doses of INV-202 for 28 days, showing decreased urinary urea and albumin excretion compared to untreated diabetic mice, along with improvements in the urinary albumin to creatinine ratio.
  • INV-202 also reduced kidney weight and podocyte loss, restored gene expression for podocyte proteins, and decreased levels of angiotensin II, indicating potential benefits for diabetic nephropathy.
View Article and Find Full Text PDF

Background: Emerging evidence supports that dihydroceramides (DhCer) and ceramides (Cer) contribute to the pathophysiology of insulin resistance and liver steatosis, and that their circulating concentrations are independently associated with cardiovascular outcomes. Circulating DhCer levels are increased in patients with type 2 diabetes (T2D). On the other hand, the GLP-1 receptor agonist liraglutide reduces major adverse cardiac events, insulin resistance and liver steatosis in T2D patients.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers developed JM-00266, a new cannabinoid 1 receptor (CB1R) blocker with limited ability to cross the blood-brain barrier, aimed at treating metabolic disorders linked to obesity.
  • Unlike its predecessor Rimonabant, JM-00266 does not affect central behaviors like food intake and anxiety, indicating it primarily acts in the periphery.
  • JM-00266 enhances glucose tolerance and insulin sensitivity in mice and promotes fat breakdown in adipose tissue, suggesting its potential for managing obesity-related metabolic issues.
View Article and Find Full Text PDF
Article Synopsis
  • White adipose tissue (WAT) contains an endocannabinoid system (ECS) that produces endocannabinoids like AEA and 2-AG, which are believed to regulate fat storage and tissue functions but have an unclear role in lipid mobilization.
  • In experiments, increasing ECS activity in WAT led to higher levels of 2-AG, which decreased lipolysis (the breakdown of fat) in both lean and obese mice, indicating that ECS may suppress fat mobilization.
  • Despite the ineffective results of acute CB1R blockade on lipolysis in obese subjects, the findings suggest that ECS activation in WAT could contribute to tissue changes that potentially lead to organ dysfunction in obesity.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers tested a new treatment, -MRI-1867, which inhibits both the cannabinoid-1 receptor (CB1R) and inducible nitric oxide synthase (iNOS) in mice with obesity due to diet.
  • The results showed that -MRI-1867 improved liver fat buildup, reduced the secretion of harmful lipoproteins, and boosted the expression of beneficial receptors, suggesting this dual-target approach could effectively treat dyslipidemia.
View Article and Find Full Text PDF
Article Synopsis
  • * In experiments, mice lacking CB₁R showed reduced preference for fatty solutions compared to wild type mice, indicating CB₁R's involvement in fat taste perception.
  • * The study found that while taste bud cells from both types of mice showed no difference in certain protein expressions, CB₁R mice had altered calcium signaling and lower GLP-1 secretion when exposed to long-chain fatty acids.
View Article and Find Full Text PDF

Diet-induced obesity (DIO) is associated with a decreased oral fat detection in rodents. This alteration has been explained by an impairment of the lipid-mediated signaling in taste bud cells (TBC). However, factors responsible for this defect remain elusive.

View Article and Find Full Text PDF

Some obese subjects overeat lipid-rich foods. The origin of this eating behavior is unknown. We have here tested the hypothesis that these subjects could be characterized by an impaired fatty taste sensitivity linked to a change in the gustatory papillae microbial and salivary environment.

View Article and Find Full Text PDF

An attraction for palatable foods rich in lipids is shared by rodents and humans. Over the last decade, the mechanisms responsible for this specific eating behavior have been actively studied, and compelling evidence implicates a taste component in the orosensory detection of dietary lipids [i.e.

View Article and Find Full Text PDF

Implication of the long-chain fatty acid (LCFA) receptor GPR120, also termed free fatty acid receptor 4, in the taste-guided preference for lipids is a matter of debate. To further unravel the role of GPR120 in the "taste of fat", the present study was conducted on GPR120-null mice and their wild-type littermates. Using a combination of morphological [i.

View Article and Find Full Text PDF

Background: The association between the orosensory detection of lipids, preference for fatty foods, and body mass index (BMI; in kg/m(2)) is controversial in humans.

Objective: We explored the oral lipid-sensing system and the orosensory-induced autonomic reflex system in lean and obese subjects.

Design: Lean (BMI: 19 to <25; n = 30) and obese (BMI >30; n = 29) age-matched men were enrolled.

View Article and Find Full Text PDF

Over the last decade, converging data have been accumulated both in rodents and humans, supporting the existence of a sixth taste modality devoted to the perception of dietary lipids. It is well known that the sense of taste is determinant for the food choice and that the overconsumption of highly palatable energy-dense foods contributes to the current obesity epidemic. Thus, an important issue in terms of Public Health is to understand the mechanisms by which the oro-sensory perception of fat is regulated.

View Article and Find Full Text PDF

A relationship between orosensory detection of dietary lipids, regulation of fat intake, and body mass index was recently suggested. However, involved mechanisms are poorly understood. Moreover, whether obesity can directly modulate preference for fatty foods remains unknown.

View Article and Find Full Text PDF

Glucagon-like peptide-1 (GLP-1) signaling modulates sweet-taste sensitivity in the mouse. Because circumvallate papillae (CVPs) express both GLP-1 and its receptor, a local regulation has been suggested. However, whether dietary lipids are involved in this regulation, as shown in the gut, is unknown.

View Article and Find Full Text PDF

Obesity and associated plethora of diseases constitute a major public health challenge worldwide. The conjunction of profound changes in our lifestyle and a thrifty genetic that evolved in an environment of food scarcity largely explains this epidemic situation. Food abundance promotes our specific appetite for the more palatable food generally rich in lipids.

View Article and Find Full Text PDF

Background: Recent studies in rodents and humans suggest that the chemoreception of long-chain fatty acids (LCFA) in oral cavity is involved in the spontaneous preference for fatty foods and might contribute to the obesity risk. CD36 and GPR120 are LCFA receptors identified in rodent taste bud cells. The fact that CD36 or GPR120 gene inactivation leads to a decrease in the preference for lipids raises the question of the respective role(s) played by these gustatory lipid-sensor candidates.

View Article and Find Full Text PDF

CD36 is a multifunctional protein homologous to the class B scavenger receptor SR-B1 mainly found in tissues with a sustained lipid metabolism and in several hematopoieic cells. CD36 is thought to be involved in various physiological and pathological processes like angiogenesis, thrombosis, atherogenesis, Alzheimer's disease or malaria. An additive emerging function for CD36 is a role as a lipid sensor.

View Article and Find Full Text PDF

Obesity constitutes a major public health problem for the twenty-first century, with its epidemic spread worldwide, particularly in children. The overconsumption of fatty foods greatly contributes to this phenomenon. Rodents and humans display a spontaneous preference for lipid-rich foods.

View Article and Find Full Text PDF

Obesity is recognized as a worldwide health problem. Overconsumption of fatty foods contributes significantly to this phenomenon. Rodents, like humans, display preferences for lipid-rich foods.

View Article and Find Full Text PDF

The sense of taste informs the body about the quality of ingested foods. Tastant-mediated signals are generated by a rise in free intracellular calcium levels ([Ca(2+)]i) in the taste bud cells and then are transferred to the gustatory area of brain via connections between the gustatory nerves (chorda tympani and glossopharyngeal nerves) and the nucleus of solitary tract in the brain stem. We have recently shown that lingual CD36 contributes to fat preference and early digestive secretions in the mouse.

View Article and Find Full Text PDF

Sense of taste informs the body about the quality of ingested foods. Five sub-modalities allowing the perception of sweet, salty, sour, bitter, and umami stimuli are classically depicted. However, the inborn attraction of mammals for fatty foods raises the possibility of an additional orosensory modality devoted to fat perception.

View Article and Find Full Text PDF

Rats and mice exhibit a spontaneous attraction for lipids. Such a behavior raises the possibility that an orosensory system is responsible for the detection of dietary lipids. The fatty acid transporter CD36 appears to be a plausible candidate for this function since it has a high affinity for long-chain fatty acids (LCFAs) and is found in lingual papillae in the rat.

View Article and Find Full Text PDF